Condition
Hip Replacement Arthroplasty
Total Trials
6
Recruiting
0
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 4 (2)
Trial Status
Completed3
Active Not Recruiting1
Terminated1
Unknown1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03505580TerminatedPrimary
AMIStem-H Radiological Assessment
NCT03724058Not ApplicableActive Not RecruitingPrimary
Fixation and Stability of the Trident® II Clusterhole HA Shells
NCT01394744CompletedPrimary
Determination of Metal Ion Serum Levels and Cytokines in Total Hip Replacement
NCT02162121Phase 4CompletedPrimary
Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia?
NCT02346513UnknownPrimary
Serum Level of Cobalt and Chromium After Ceramic on Metal Articulation Total Hip Arthroplasty
NCT00542516Phase 4CompletedPrimary
Comparison Between Two Techniques of Volemic Expansion in Hip Replacement Arthroplasty
Showing all 6 trials